Alterity Therapeutics Limited (PBN) — Working Capital to Net Assets Ratio
Alterity Therapeutics Limited (PBN) has a Working Capital to Net Assets ratio of 99.9% as of December 2025. Working capital of €54.24 Million (current assets of €56.82 Million minus current liabilities of €2.59 Million) is measured against net assets of €54.27 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See PBN days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Alterity Therapeutics Limited Working Capital to Net Assets (2014–2025)
This chart shows how Alterity Therapeutics Limited's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 99.9%, reflecting working capital of €54.24 Million against net assets of €54.27 Million EUR. For the complete balance sheet picture, see balance sheet size of Alterity Therapeutics Limited.
Annual Working Capital to Net Assets for Alterity Therapeutics Limited (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Alterity Therapeutics Limited from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Alterity Therapeutics Limited liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.8% | €42.34 Million | €42.40 Million | €45.87 Million | €3.53 Million | ▲ +0.8 pp |
| 2024 | 99.0% | €13.66 Million | €13.80 Million | €19.04 Million | €5.37 Million | ▼ -0.3 pp |
| 2023 | 99.4% | €22.67 Million | €22.81 Million | €27.05 Million | €4.38 Million | ▼ -0.2 pp |
| 2022 | 99.6% | €35.32 Million | €35.47 Million | €41.14 Million | €5.82 Million | ▼ -0.2 pp |
| 2021 | 99.8% | €30.42 Million | €30.47 Million | €33.49 Million | €3.07 Million | ▲ +0.2 pp |
| 2020 | 99.6% | €7.12 Million | €7.15 Million | €9.84 Million | €2.71 Million | ▼ -0.3 pp |
| 2019 | 99.9% | €16.54 Million | €16.55 Million | €19.86 Million | €3.32 Million | ▲ +0.4 pp |
| 2018 | 99.6% | €16.01 Million | €16.08 Million | €18.65 Million | €2.64 Million | ▼ -0.3 pp |
| 2017 | 99.9% | €23.66 Million | €23.69 Million | €25.25 Million | €1.59 Million | ▲ +0.1 pp |
| 2016 | 99.8% | €31.30 Million | €31.37 Million | €33.66 Million | €2.36 Million | ▲ +0.0 pp |
| 2015 | 99.8% | €39.03 Million | €39.11 Million | €41.74 Million | €2.72 Million | ▲ +0.0 pp |
| 2014 | 99.8% | €37.60 Million | €37.69 Million | €41.55 Million | €3.95 Million | — |